⚠️ JAN 12 – FEB 6 CYBERATTACK: ALL ORDERS REFUNDED • DO NOT PURCHASE UNTIL FURTHER NOTICE • CONTACT support@anubis.estate FOR REFUND STATUS
Compassionate useThyroid Analog

Compound 61625

Formula Pending

Molecular Mass
N/A
CAS Registry
AUTO-061625
Risk Class
HIGH
Last Audit
May 12, 2108

Research Abstract

Thyroid Analog candidate engineered for metabolic regulation initiatives with automated dossier coverage.

Compound 61625 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.

The dossier currently sits in compassionate use with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.

Supply records cite CAS AUTO-061625 with updates logged 2108-05-12.

Acquisition Protocol

Authorized research personnel may request deployment of this compound for laboratory analysis.

Primary Vectors

Metabolic regulationCardiometabolic recovery

Nomenclature

CX-61625Thyroid Analog Program 61625

Reference Material

  1. [1] Anubis Compound Registry • CAS AUTO-061625
  2. [2] Operations Pulse • Thyroid Analog innovation track
  3. [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61625